China Healthcare: Macro Themes
This Insight summarizes the takeaways from a recent China healthcare industry conference. There is much talk of pressures on the industry, but...
461 Views
Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?
This article analyzed the market potential of TAVR in China, competition pattern of key players, financial position of MicroPort CardioFlow and...
410 Views
Varian-Siemens Deal: DAX Promotion on the Cards for the Acquirer
This is the largest healthcare sector M&A Deal announced so far in 2020. Earlier this year, in March, Thermo Fisher Scientific Inc (TMO US)...
487 Views
Peijia Medical (沛嘉医疗) Pre-IPO: Deserves Valuation Premium for the TAVR Late Comer
Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...
403 Views
Peijia Medical IPO Initiation: Let's Have a Heart-To-Heart
Peijia Medical (1740651D CH) is a leading transcatheter heart valve medical device company in China. It has filed for a Hong Kong IPO and is...
339 Views